Scilex Holding Company
NASDAQ: SCLX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Henry H. Ji
- Employees
- 115
- Headquarters
- Palo Alto, United States
- IPO year
- 2021
- Market cap
- $58.3M
- Website
- https://www.scilexholding.com
Loading SCLX…
Loading profile data…Frequently asked questions about SCLX
What does Scilex Holding Company (SCLX) do?
Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort as...
Where does SCLX trade?
Scilex Holding Company (SCLX) trades on the NASDAQ Capital Market.
What sector is SCLX in?
Scilex Holding Company (SCLX) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Scilex Holding Company?
Henry H. Ji is the chief executive officer of Scilex Holding Company (SCLX).
Where is Scilex Holding Company headquartered?
Scilex Holding Company is headquartered in United States.
Does SCLX pay a dividend?
Scilex Holding Company (SCLX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SCLX go public?
Scilex Holding Company (SCLX) completed its initial public offering in 2021.